Ozempic: The Hidden Costs of a Quick Fix - AI Podcast

Story at-a-glance Ozempic users risk losing essential lean muscle and bone mass, making them physically weaker and shortening their lifespan GLP-1 drugs like Ozempic dull emotional responses, reduce life satisfaction, and significantly increase risks of depression and suicidal thoughts by altering brain chemistry and dopamine regulation After discontinuing semaglutide, many users regain more fat than they lost, with a worse fat-to-muscle ratio, as hunger returns and muscle loss remains unrecovered Common GI symptoms could escalate into dangerous conditions like gastroparesis, where digestion slows or halts, leading to vomiting, nutrient deficiency, and chronic digestive distress Since 2018, 62,000 adverse events and 162 deaths linked to Ozempic-type drugs have been reported, with a surge following increased marketing and prescriptions after 2022

There are no comments yet.

Please log in to write the first comment.